Coronavirus disease

Sort Help
entries

Results

All (50)

All (50) (0 to 10 of 50 results)

Data (18)

Data (18) (0 to 10 of 18 results)

  • Table: 13-10-0863-01
    Geography: Canada, Geographical region of Canada
    Frequency: Occasional
    Description: In collaboration with the Public Health Agency of Canada (PHAC), this table provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary. This table will provide an aggregate summary of the data available in the publication 13-26-0003.
    Release date: 2024-07-12

  • Table: 13-10-0864-01
    Geography: Canada, Geographical region of Canada
    Frequency: Occasional
    Description: In collaboration with the Public Health Agency of Canada (PHAC), this table provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary. This table will provide an aggregate summary of the data available in the publication 13-26-0003.
    Release date: 2024-07-12

  • Table: 13-26-0003
    Description:

    In collaboration with the Public Health Agency of Canada (PHAC), this data file provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary.

    Release date: 2024-07-12

  • Table: 13-10-0867-01
    Geography: Canada
    Frequency: Occasional
    Description: Long term symptoms were defined as having COVID-19 symptoms at least 3 months after a self-reported positive test or suspected SARS-CoV-2 infection. Results on the status of long-term symptoms only included respondents for whom a period of three months separated their self-reported date of infection and the date they completed the questionnaire.
    Release date: 2023-08-03

  • Table: 13-10-0868-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.
    Release date: 2023-08-03

  • Public use microdata: 13-25-0009
    Description: This public use microdata file (PUMF) provides researchers access to data on the distribution of SARS-CoV-2 lineages detected in the Canadian provinces between May and September 2022. Samples were collected as part of the Canadian COVID-19 Antibody and Health Survey (CCAHS), Cycle 2. The PUMF file consists of a subset of participants of the CCAHS who submitted a positive PCR saliva sample over the course of the collection of the survey. The PUMF contains select demographic information including sex at birth, age group, province and the week of collection. The file also contains SARS-CoV-2 whole genome sequences and its associated data.
    Release date: 2023-05-25

  • Table: 13-10-0865-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Semi-annual
    Description: This table presents a series of indicators relating to the COVID-19 pandemic, including relating to perceptions of Canadians' mental health, precautions they've taken, willingness to receive vaccine and the number of vaccinated and unvaccinated persons. Estimates are based on preliminary bi-annual data from the Canadian Community Health Survey, and are provided for the Canadian population aged 18 and older excluding the territories, by region of residence and other demographic characteristics.
    Release date: 2023-04-25

  • Table: 13-10-0866-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.
    Release date: 2023-03-27

  • Table: 13-10-0774-01
    Geography: Canada, Geographical region of Canada
    Frequency: Occasional
    Description:

    In collaboration with the Public Health Agency of Canada (PHAC), this table provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary. This table will provide an aggregate summary of the data available in the publication 13-26-0003.

    Release date: 2022-11-04

  • Table: 13-10-0775-01
    Geography: Canada, Geographical region of Canada
    Frequency: Occasional
    Description:

    In collaboration with the Public Health Agency of Canada (PHAC), this table provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary. This table will provide an aggregate summary of the data available in the publication 13-26-0003.

    Release date: 2022-11-04
Analysis (28)

Analysis (28) (0 to 10 of 28 results)

Reference (4)

Reference (4) ((4 results))

  • Surveys and statistical programs – Documentation: 13-26-0002
    Description:

    Created in collaboration with the Public Health Agency of Canada (PHAC), this user guide with appended data dictionary provides Canadians and researchers with required information to be able to utilize the Detailed preliminary information on confirmed cases of COVID-19 (Revised) table.

    The user guide with appended data dictionary describes background information of COVID-19 as well as objectives, coverage, content, limitations and data quality concerns of the table.

    Release date: 2024-01-12

  • Surveys and statistical programs – Documentation: 5319
    Description: The data contain detailed confirmed cases of coronavirus disease (COVID-19) in Canada, which is compiled by the Public Health Agency of Canada, with the contribution from provincial and territorial Health ministries.

  • Surveys and statistical programs – Documentation: 5339
    Description: This follow-up to the Canadian COVID-19 Antibody and Health Survey (CCAHS - Follow-up Questionnaire, 2023) collected new and updated information about health. The questions touched on changes in vaccination status, reinfection with the virus that causes COVID-19, symptoms of COVID-19 and impact on daily life, health conditions and the use of health care services.

  • Surveys and statistical programs – Documentation: 5340
    Description: The purpose of this crowdsource questionnaire is to understand the impacts of COVID-19 on Canadian health care workers, with particular focus on access to personal protective equipment (PPE) and infection prevention and control (IPC) measures in the workplace.
Date modified: